Rosen Law Firm Initiates Class Action Against Hims & Hers Health

The lawsuit contends that Hims & Hers failed to disclose that it shared sensitive consumer health information with third-party advertising platforms. Furthermore, the complaint alleges the company misrepresented its consultation process, charging customers for prescriptions immediately after intake forms were submitted, despite claims that providers would first identify a treatment tailored to the individual. These undisclosed practices, the suit claims, invited significant regulatory scrutiny and potential financial penalties, rendering the company’s public statements about its business operations materially misleading.

Investors seeking to serve as lead plaintiff must file their motion with the court by November 2, 2026. While the litigation is ongoing, no class has yet been certified. Shareholders are not required to take action to remain absent class members, and their eligibility for potential future recovery is not contingent upon serving as a lead representative. Those interested in participating or seeking further information can contact Phillip Kim at Rosen Law Firm.